MX2022001204A - Métodos de identificación de receptores de linfocitos t. - Google Patents
Métodos de identificación de receptores de linfocitos t.Info
- Publication number
- MX2022001204A MX2022001204A MX2022001204A MX2022001204A MX2022001204A MX 2022001204 A MX2022001204 A MX 2022001204A MX 2022001204 A MX2022001204 A MX 2022001204A MX 2022001204 A MX2022001204 A MX 2022001204A MX 2022001204 A MX2022001204 A MX 2022001204A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- identifying
- mhc class
- certain aspects
- beta chain
- Prior art date
Links
- 210000001744 T-lymphocyte Anatomy 0.000 title abstract 2
- 102000043131 MHC class II family Human genes 0.000 abstract 2
- 108091054438 MHC class II family Proteins 0.000 abstract 2
- 108091008874 T cell receptors Proteins 0.000 abstract 2
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 abstract 2
- 102000018713 Histocompatibility Antigens Class II Human genes 0.000 abstract 1
- 108010027412 Histocompatibility Antigens Class II Proteins 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56977—HLA or MHC typing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/30—Cellular immunotherapy characterised by the recombinant expression of specific molecules in the cells of the immune system
- A61K40/32—T-cell receptors [TCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/7051—T-cell receptor (TcR)-CD3 complex
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/70539—MHC-molecules, e.g. HLA-molecules
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962880492P | 2019-07-30 | 2019-07-30 | |
| US202063029103P | 2020-05-22 | 2020-05-22 | |
| PCT/IB2020/057176 WO2021019476A1 (en) | 2019-07-30 | 2020-07-29 | Methods of identifying t cell receptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022001204A true MX2022001204A (es) | 2022-05-03 |
Family
ID=74228602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022001204A MX2022001204A (es) | 2019-07-30 | 2020-07-29 | Métodos de identificación de receptores de linfocitos t. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220291215A1 (enExample) |
| EP (1) | EP4004546A4 (enExample) |
| JP (2) | JP7724203B2 (enExample) |
| KR (1) | KR20220052941A (enExample) |
| CN (1) | CN114761802B (enExample) |
| AU (1) | AU2020321710A1 (enExample) |
| CA (1) | CA3146290A1 (enExample) |
| IL (1) | IL290226A (enExample) |
| MX (1) | MX2022001204A (enExample) |
| TW (1) | TW202118779A (enExample) |
| WO (1) | WO2021019476A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113795583B (zh) | 2019-03-04 | 2026-03-27 | 大学健康网络 | T细胞受体及其使用方法 |
| WO2021019473A1 (en) | 2019-07-30 | 2021-02-04 | University Health Network | Mhc class ii molecules and methods of use thereof |
| WO2021019475A1 (en) * | 2019-07-30 | 2021-02-04 | University Health Network | Mhc class ii molecules and methods of use thereof |
| CN118662607A (zh) * | 2023-03-15 | 2024-09-20 | 中国科学院上海巴斯德研究所 | 抑制过激炎性反应的蛋白及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012120488A (ja) * | 2010-12-09 | 2012-06-28 | Univ Of Tokyo | 新規安定化組換えｍｈｃタンパク質 |
| MX2020003117A (es) * | 2017-09-20 | 2020-08-20 | Us Health | Receptores de celulas t restringidas a hla de clase ii contra ras mutado. |
-
2020
- 2020-07-29 WO PCT/IB2020/057176 patent/WO2021019476A1/en not_active Ceased
- 2020-07-29 CA CA3146290A patent/CA3146290A1/en active Pending
- 2020-07-29 JP JP2022506465A patent/JP7724203B2/ja active Active
- 2020-07-29 KR KR1020227006937A patent/KR20220052941A/ko active Pending
- 2020-07-29 AU AU2020321710A patent/AU2020321710A1/en active Pending
- 2020-07-29 US US17/631,818 patent/US20220291215A1/en active Pending
- 2020-07-29 CN CN202080063987.5A patent/CN114761802B/zh active Active
- 2020-07-29 TW TW109125671A patent/TW202118779A/zh unknown
- 2020-07-29 MX MX2022001204A patent/MX2022001204A/es unknown
- 2020-07-29 EP EP20848442.8A patent/EP4004546A4/en active Pending
-
2022
- 2022-01-30 IL IL290226A patent/IL290226A/en unknown
-
2025
- 2025-08-04 JP JP2025130081A patent/JP2025166836A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL290226A (en) | 2022-03-01 |
| JP2022542445A (ja) | 2022-10-03 |
| KR20220052941A (ko) | 2022-04-28 |
| CA3146290A1 (en) | 2021-02-04 |
| WO2021019476A1 (en) | 2021-02-04 |
| AU2020321710A1 (en) | 2022-03-03 |
| JP7724203B2 (ja) | 2025-08-15 |
| TW202118779A (zh) | 2021-05-16 |
| CN114761802B (zh) | 2026-04-28 |
| EP4004546A1 (en) | 2022-06-01 |
| EP4004546A4 (en) | 2024-10-09 |
| CN114761802A (zh) | 2022-07-15 |
| JP2025166836A (ja) | 2025-11-06 |
| US20220291215A1 (en) | 2022-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2022000281A2 (es) | Receptores de linfocitos t de mage-a4 y métodos de uso de estos | |
| MX2020010235A (es) | Vectores de expresion para receptores de engullimiento quimerico, celulas hospederas geneticamente modificadas y usos de los mismos. | |
| CR20170351A (es) | Proteínas de unión a icos | |
| MX2014014801A (es) | Metodo para la seleccion y produccion de entidades dirigidas altamente selectivas hechas a la medida y multiespecificas que contienen por lo menos dos entidades de union diferentes y usos de las mismas. | |
| CY1121962T1 (el) | Υποδοχεις τ κυτταρου | |
| MX2021005155A (es) | Anticuerpo biespecífico y uso del mismo. | |
| EA202091335A1 (ru) | Ограниченные hla класса i t-клеточные рецепторы против мутантного ras | |
| PE20191651A1 (es) | Anticuerpos agonistas anti-icos y sus usos | |
| TR201911010A2 (tr) | Benzeti̇lmi̇ş tavlama tabanli bi̇r yaklaşimla bulutta görev çi̇zelgeleme yapilmasini sağlayan yöntem | |
| BR112022001702A2 (pt) | Moléculas mhc classe ii e métodos de uso das mesmas | |
| BR112012017124B8 (pt) | método para produzir e para purificar um multímero polipeptídico | |
| MX2023000738A (es) | Proteinas de union a antigeno que activan el receptor de leptina. | |
| EA202090652A1 (ru) | T-клеточные рецепторы, рестриктированные по антигену лейкоцитов человека класса ii, против мутантного ras | |
| AR083295A1 (es) | Metodo para activar celulas t auxiliares | |
| BR112014025384A8 (pt) | método e sistema para executar ensaio automatizado e métodos para executar teste reflexivo em vários exemplares | |
| EA201390011A1 (ru) | Т-клеточные рецепторы | |
| CR20220330A (es) | Anticuerpos anti-ly6g6d y métodos de uso. | |
| SA519410534B1 (ar) | أجسام مضادة لعامل مساعد لموهن الخلايا الليمفاوية البائية والتائية واستخداماتها | |
| CL2025001526A1 (es) | Composición para inmunoterapia | |
| BR112013004594A2 (pt) | método para a determinação de um conteúdo de antígeno | |
| CR20220065A (es) | Método para la caracterización de polipéptidos que se unen a complejos de péptido:mhc | |
| WO2018160874A8 (en) | CLASSIFICATION OF CELLS BASED ON A MECHANICAL SIGNATURE OF THE CORE | |
| ZA202102546B (en) | Methods for identifying free thiols in proteins | |
| MX2022001210A (es) | Moléculas de complejo mayor de histocompatibilidad (mhc) de clase ii y métodos para su uso. | |
| BR112016018826A8 (pt) | anticorpo purificado, ou fragmento de ligação de antígeno, método para a identificação de uma população de células de esperma de mamífero portadoras de cromossomo x, e método in vitro para distorcer uma proporção entre os sexos |